Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

ESSA Pharma Inc EPIX

Healthcare Biotechnology
ESSA Pharma Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is focused on developing proprietary therapies for the treatment of patients with prostate cancer. Its lead candidate, EPI-7386, is an oral, small molecule that inhibits the N-terminal domain of the androgen receptor (AR). The Company is completing the initial Phase I clinical development of EPI-7386 as a monotherapy treatment for patients with metastatic castration-resistant prostate cancer (mCRPC). The Company is also developing ANITen bAsed Chimera (ANITAC) AR NTD degraders to suppress androgen biology.


NDAQ:EPIX - Post by User

ESSA Pharma Inc > Level 2 please....
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(1)
•••
Comment by SilentRiveron Sep 17, 2019 8:49am
62 Views
Post# 30134572

RE:RE:Level 2 please....

RE:RE:Level 2 please....
$3.90
-$0.00
(0.00%)
 3.60 (1) 4.05 (1) 0 0.00 - 0.00
Buy
Sell
Hide Level Two Quotes
# Orders Shares Bid Ask Shares # Orders
1 100 3.600 4.050 100 1
1 100 3.350 4.250 300 2
1 2300 3.250 4.950 1400 1
1 10000 3.150 5.350 800 1
1 100 2.900 6.880 200 1

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities